{"id":29313,"date":"2026-03-18T16:16:22","date_gmt":"2026-03-18T16:16:22","guid":{"rendered":"https:\/\/wagners1.wpenginepowered.com\/class-actions\/yasmin\/"},"modified":"2026-05-22T19:20:29","modified_gmt":"2026-05-22T19:20:29","slug":"yasmin","status":"publish","type":"class-action","link":"https:\/\/wagners.co\/es\/class-actions\/yasmin\/","title":{"rendered":"Yasmin"},"content":{"rendered":"\n

Pauley v. Bayer Corporation et al<\/h3>\n

Nova Scotia Supreme Court File: Hfx No. 330493<\/h3>\nOn June 10, 2010, Wagners Law Firm filed a proposed common law class proceeding on behalf of all Canadian residents who have been prescribed the birth control medication known as Yasmin and Yaz.\n\nYasmin & Yaz (which are manufactured by Bayer AG and its subsidiaries) are prescription birth control medications which unlike other contraceptives on the market contain a \u201cfourth generation\u201d progestin called drospirenone. Yasmin and Yaz were approved for sale in Canada in 2004 and 2008 respectively. During the brief time that Yasmin and Yaz have been approved for sale in Canada, a total of over 120 reports of injury and death have been submitted to Health Canada in association with the Defendants\u2019 products. Among the more common complaints are cases of deep vein thrombosis, blood clots, strokes, heart attacks, and pulmonary embolisms.\n\nNumerous studies and papers have been published in reputable journals concerning the safety of both Yasmin and Yaz.\n\nIn April 2002, the British Medical Journal reported that the Dutch College of Medical Practitioners recommended that older, second generation birth control pills be prescribed instead of Yasmin as a result of 40 cases of venous thrombosis among women who had taken Yasmin.\n\nIn February 2003, a paper entitled Thromboembolism Associated with the New Contraceptive Yasmin was published in the British Medical Journal detailing a Netherlands Pharmacovigilance Centre report of five additional reports of thromboembolism, including two deaths, where Yasmin was suspected to be the cause.\n\nMore recently, in August 2009, the British Medical Journal published the results of a national follow-up study which concluded the oral contraceptives containing drospirenone, such as Yasmin and Yaz, are associated with a significantly higher risk of venous thromboembolism than other oral contraceptives.\n\nPatients taking Yasmin or Yaz should consult with their physician should they have any concerns with regard to continuing or discontinuing their use of Yasmin or Yaz.\n\nIf you or a loved have experienced deep vein thrombosis, blood clots, stroke, heart attacks, or pulmonary embolisms, please contact the offices of Wagners Law Firm at (902) 425-7330 or 1-800-INJURY4 (1-800-465-8794) to be included as a proposed class member in the lawsuit.\n\nWagners is presently accepting enquiries from residents of Canada who have suffered deep vein thrombosis, blood clots, stroke, heart attacks, pulmonary embolisms and\/or other adverse effects associated with the use of Yasmin or Yaz.\n\nIf you, or a member of your family, have taken Yasmin or Yaz and serious side effects have resulted, you may be eligible to be included as a Class Member in our proposed class action lawsuit.\n","protected":false},"excerpt":{"rendered":"

Wagners commenced a proposed class action on behalf of all Canadians prescribed the birth control medications known as Yasmin and Yaz.<\/p>\n","protected":false},"featured_media":0,"parent":0,"menu_order":0,"template":"","format":"standard","meta":{"_acf_changed":false},"class-action-status":[14],"class_list":["post-29313","class-action","type-class-action","status-publish","format-standard","hentry","class-action-status-open"],"acf":[],"_links":{"self":[{"href":"https:\/\/wagners.co\/es\/wp-json\/wp\/v2\/class-action\/29313","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wagners.co\/es\/wp-json\/wp\/v2\/class-action"}],"about":[{"href":"https:\/\/wagners.co\/es\/wp-json\/wp\/v2\/types\/class-action"}],"wp:attachment":[{"href":"https:\/\/wagners.co\/es\/wp-json\/wp\/v2\/media?parent=29313"}],"wp:term":[{"taxonomy":"class-action-status","embeddable":true,"href":"https:\/\/wagners.co\/es\/wp-json\/wp\/v2\/class-action-status?post=29313"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}